🎁 Black Friday: 50% off Unlimited and 30% off Pro annual plans
Integrated BioPharma, Inc. (INBP)
OTCMKTS · Delayed Price · Currency is USD
0.1600
0.00 (0.00%)
At close: Nov 19, 2026

Integrated BioPharma Income Statement

Millions USD. Fiscal year is Jul - Jun.
Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
41.143.8754.3550.3250.6756.25
Revenue Growth
-23.08%-19.28%8.02%-0.70%-9.91%-11.51%
Cost of Revenue
41.4343.0748.7946.4346.6149.69
Gross Profit
-0.330.85.563.884.066.55
Selling, General & Admin
3.53.513.543.633.943.81
Operating Expenses
3.53.513.543.633.943.81
Operating Income
-3.83-2.712.020.250.122.75
Interest Expense
-0.01-0.01-0.05-0.05-0.01-0.13
Interest & Investment Income
0.170.170.090.07--
Other Non Operating Income (Expenses)
0.020.01--0-0.010.01
EBT Excluding Unusual Items
-3.66-2.542.060.270.12.63
Gain (Loss) on Sale of Investments
------0.06
Gain (Loss) on Sale of Assets
0.010.010.03--0.02
Asset Writedown
-0.03-0.03-0.03---
Pretax Income
-3.68-2.562.060.270.12.6
Income Tax Expense
-0.030.281.250.160.13-1.24
Net Income
-3.66-2.840.810.11-0.033.84
Net Income to Common
-3.66-2.840.810.11-0.033.84
Net Income Growth
--621.43%---52.10%
Shares Outstanding (Basic)
313130303030
Shares Outstanding (Diluted)
313131313032
Shares Change
-0.96%-0.35%0.95%3.08%-7.34%0.65%
EPS (Basic)
-0.12-0.090.030.00-0.000.13
EPS (Diluted)
-0.12-0.090.030.00-0.000.12
EPS Growth
--635.32%---52.00%

Additional Metrics

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
Free Cash Flow
-1.580.91.870.391.123.61
Free Cash Flow Per Share
-0.050.030.060.010.040.11
Gross Margin
-0.80%1.82%10.23%7.72%8.01%11.65%
Operating Margin
-9.32%-6.17%3.72%0.50%0.24%4.88%
Profit Margin
-8.90%-6.48%1.49%0.22%-0.07%6.82%
Free Cash Flow Margin
-3.84%2.04%3.45%0.78%2.20%6.41%
EBITDA
-3.55-2.412.340.560.473.08
EBITDA Margin
-8.63%-5.50%4.30%1.11%0.93%5.48%
D&A For EBITDA
0.280.290.320.310.350.34
EBIT
-3.83-2.712.020.250.122.75
EBIT Margin
-9.32%-6.17%3.72%0.50%0.24%4.88%
Effective Tax Rate
--60.81%58.21%134.00%-